iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment... Show more
Industry MedicalNursingServices
A.I.dvisor tells us that ITOC and PFSA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ITOC and PFSA's prices will move in lockstep.
| Ticker / NAME | Correlation To ITOC | 1D Price Change % | ||
|---|---|---|---|---|
| ITOC | 100% | -0.43% | ||
| PFSA - ITOC | 30% Poorly correlated | -2.80% | ||
| PEN - ITOC | 26% Poorly correlated | -0.02% | ||
| APYX - ITOC | 25% Poorly correlated | +0.35% | ||
| NEOG - ITOC | 21% Poorly correlated | +0.08% | ||
| MDAI - ITOC | 20% Poorly correlated | +2.56% | ||
More | ||||
| Ticker / NAME | Correlation To ITOC | 1D Price Change % |
|---|---|---|
| ITOC | 100% | -0.43% |
| Medical/Nursing Services industry (141 stocks) | 3% Poorly correlated | +0.38% |
| Health Services industry (242 stocks) | 3% Poorly correlated | +0.38% |
ITOC saw its Momentum Indicator move below the 0 level on September 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator turned negative. In 30 of the 31 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ITOC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The Moving Average Convergence Divergence (MACD) for ITOC just turned positive on August 27, 2026. Looking at past instances where ITOC's MACD turned positive, the stock continued to rise in 12 of 13 cases over the following month. The odds of a continued upward trend are 90%.
ITOC moved above its 50-day moving average on September 02, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for ITOC crossed bullishly above the 50-day moving average on August 31, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 90%.
Following a +18.86% 3-day Advance, the price is estimated to grow further. Considering data from situations where ITOC advanced for three days, in 76 of 81 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
The Aroon Indicator entered an Uptrend today. In 30 of 30 cases where ITOC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 90%.
The Tickeron Valuation Rating of 21 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.844) is normal, around the industry mean (10.685). P/E Ratio (0.000) is within average values for comparable stocks, (67.907). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.653). ITOC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (9.294) is also within normal values, averaging (35.925).
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. ITOC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ITOC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.